Catheter Precision (VTAK)

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

的Catheter Precision, Inc.（VTAK）股票的价格今天是$1.55，自市场开启。该公司市值为$269.54万，日交易量为$1.00股。前一交易日收盘价为 $1.52。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Catheter Precision股票的指南。